Radiotherapy in low-grade gliomas: Cons

Area of Science:

• Neuro-oncology
• Radiation oncology
• Clinical trial analysis

Background:

• Postoperative radiotherapy (RT) is frequently used for low-grade gliomas (LGGs), but its efficacy is debated due to disease heterogeneity.
• Retrospective studies show conflicting results regarding RT benefit in LGGs, confounded by patient selection and treatment variables.
• The heterogeneity of LGGs, encompassing diverse histologies and cytogenetic patterns, complicates treatment evaluation.

Discussion:

• A single prospective randomized trial found no survival benefit for immediate postoperative RT versus observation in LGGs.
• This trial did show a modest improvement in time to progression with immediate RT, but delayed RT was given to many in the observation arm.
• The findings suggest RT is active in LGGs, but delayed application may yield comparable survival outcomes to immediate postoperative RT.

Key Insights:

• Immediate postoperative RT for LGGs did not improve overall survival compared to observation in a randomized trial.
• Delayed RT administration appears to provide similar survival benefits as immediate RT, potentially mitigating risks.
• High-dose or whole-brain RT can lead to significant cognitive deficits, underscoring the need for cautious application.

Outlook:

• Routine postoperative RT for LGGs is not recommended.
• If RT is necessary for symptomatic or progressive disease, conservative doses (
• Future RT use in LGGs should ideally be confined to clinical research protocols to better define its role and optimize treatment.